Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) and Marpai (NASDAQ: MRAI) Direct comparison

0

Marpai (NASDAQ: MRAIGet a rating) and Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) are both business services companies, but which is the better investment? We’ll compare the two companies based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations and institutional ownership.

Analyst Notes

This is a summary of recent ratings and recommendations for Marpai and Fresenius Medical Care AG & Co. KGaA, as provided by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Marpai 0 0 0 0 N / A
Fresenius Medical Care AG & Co. KGaA 2 7 5 0 2.21

Fresenius Medical Care AG & Co. KGaA has a consensus target price of $54.10, suggesting a potential upside of 62.22%. Given Fresenius Medical Care AG & Co. KGaA’s likely higher upside, analysts clearly believe that Fresenius Medical Care AG & Co. KGaA is more favorable than Marpai.

Profitability

This table compares the net margins, return on equity and return on assets of Marpai and Fresenius Medical Care AG & Co. KGaA.

Net margins Return on equity return on assets
Marpai N / A N / A N / A
Fresenius Medical Care AG & Co. KGaA 5.51% 7.51% 2.99%

Benefits and evaluation

This table compares the gross revenue, earnings per share, and valuation of Marpai and Fresenius Medical Care AG & Co. KGaA.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Marpai $14.23 million 1.93 -$15.98 million N / A N / A
Fresenius Medical Care AG & Co. KGaA $20.85 billion 0.94 $1.15 billion $1.96 17.02

Fresenius Medical Care AG & Co. KGaA has higher revenue and profit than Marpai.

Institutional and insider ownership

47.4% of Marpai shares are held by institutional investors. By comparison, 4.9% of the shares of Fresenius Medical Care AG & Co. KGaA are held by institutional investors. Strong institutional ownership indicates that large money managers, endowments, and hedge funds believe a stock will outperform the market over the long term.

Summary

Fresenius Medical Care AG & Co. KGaA beats Marpai on 7 out of 9 factors compared between the two stocks.

About Marpai (Get a rating)

Marpai, Inc., a technology-driven healthcare payer, is focused on providing services to the self-insured employer market. It also offers ancillary services, such as care management, case management, actuarial services, administration of health savings accounts, and cost containment services. The company was incorporated in 2021 and is based in Tampa, Florida.

About Fresenius Medical Care AG & Co. KGaA (Get a rating)

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure. The company also develops, manufactures and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granules, bloodlines, kidney pharmaceuticals and water treatment systems; and non-dialyzed products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires and licenses renal pharmaceuticals; provides kidney medications and supplies to patients at home or in dialysis clinics; and provides vascular, cardiovascular and endovascular specialty services, an outpatient vascular surgery center, and nephrology and cardiology medical services. The company sells its products directly to dialysis clinics, hospitals and specialty treatment clinics, as well as through local sales forces, independent distributors, resellers and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.



Get news and reviews for Marpai Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Marpai and related companies with MarketBeat.com’s FREE daily newsletter.

Share.

Comments are closed.